An Act relative to the administration of anti-psychotic or other psychotropic substances to nursing home residents
Accompanied a study order, see S2972
Email me when S 1420 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 1420. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill adds a definition of psychotropic drugs and mandates that nursing homes submit quarterly antipsychotic medication reports, post them publicly, and include detailed prescribing information in each resident’s care plan. It also sets monetary penalties and possible admission suspensions for facilities that fail to report. The goal is to increase transparency and protect residents from unnecessary medication.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 1420
3 free questions a day, no accountHearings
- Patient Rights and Carceral HealthJoint Committee on Mental Health, Substance Use and Recovery · Oct 14, 2025
History
- Accompanied a study order, see S2972
- Bill reported favorably by committee and referred to the committee on Health Care Financing
- Hearing scheduled for 10/14/2025 from 01:00 PM-05:00 PM in A-2
- Referred to the committee on Mental Health, Substance Use and Recovery
- House concurred
Sponsors
- Bruce E. Tarr (R) · sponsor
- James B. Eldridge
- Joanne M. Comerford
- Peter J. Durant
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 1420 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 1420 freeOr ask your AI assistant about S 1420 directly:
Add to Claude, ChatGPT or Cursor